Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Soliqua 100/33 (active ingredients: insulin glargine and lixisenatide) subcutaneous injection Initial FDA Approval: 2016 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
Bacteriostatic Water is sterile water that contains 0.9% benzyl alcohol, a bacteriostatic agent that prevents bacterial growth
Key takeaway: GLP-1 RAs do not appear to increase pancreatitis risk, and may be associated with improved outcomes if pancreatitis occurs
Pathogens or cellular debris induce heightened expression of pro-inflammatory cytokines such as IFNs and LPS, prompting microglial activation from a resting state (47)
Selecting ALC for treating your fibromyalgia is not as tricky as PEA
